Akèy › Timè nan sèvo › Kalifòni
Etid klinik pou Timè nan sèvo nan Kalifòni
39 etid pou Timè nan sèvo ap chèche patisipan nan sit nan Kalifòni.
Vil nan Kalifòni
Tèks ofisyèl etid la (Anglè)
Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures
- Stanford Cancer Center, Stanford
Ap rekriteFaz 1/2
6 Months – 25 Years · Tout sèks · Mizajou Sep 29, 2026 · NCT04085887Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- UCSD Moores Cancer Center, La Jolla
- Cedars-Sinai Medical Center, Los Angeles
- Stanford University, Palo Alto
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07326566Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Precision NextGen Oncology, Beverly Hills
- OPN Healthcare, Inc, Glendale
- University of Southern California, Los Angeles
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06047379Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
- Cedars-Sinai Medical Center, Los Angeles
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT04977375PilotStudyAssessSafeActiveSurveillancApproachLocalThe Pa w/BrainMetsUndergoinCNSPenetratSystemicThe
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07827001Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- The Angeles clinic - A cedars SINAI AFFILIATE, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
- University of California, San Francisco (UCSF), San Francisco
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT05786924A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Local Institution - 0096, San Francisco
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07492680A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank
- Epic Care-Dublin, Dublin
- Bay Area Breast Surgeons Inc, Emeryville
- ak 9 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04511013Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- Lucille Packard Children's Hospital Stanford, Palo Alto
Ap rekriteFaz 2
59 Months · Tout sèks · Mizajou Sep 15, 2026 · NCT05535166GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
- Lucile Packard Children's Hospital Stanford, Palo Alto
Ap rekriteFaz 1
Laj 1 a 30 · Tout sèks · Mizajou Sep 11, 2026 · NCT07087002A Phase 1/1b Study of IAM1363 in HER2 Cancers
- UCSD Moores Cancer Center, La Jolla
- USC Norris Comprehensive Cancer Center, Los Angeles
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06253871Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Providence Medical Foundation, Fullerton
- California Research Institute, Los Angeles
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT05386108UCSD Image-Guided Cognitive-Sparing Radiosurgery for Intracranial Lesions
- Moores Cancer Center, San Diego
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT04343157A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- Providence - Saint John's Health Center, Santa Monica
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT07428616Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
- University of California, San Francisco, San Francisco
Ap rekriteEtid obsèvasyon
Laj 4 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT06474533A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
- City of Hope--Duarte, Duarte
- Univ. of California Los Angeles, Los Angeles
- Scripps Health, San Diego
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT06764940Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
- Hoag Memorial Hospital Presbyterian, Newport Beach
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Aug 19, 2026 · NCT05317858A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab
- City of Hope Medical Center, Duarte
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT07619599Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
- Children's Hospital Los Angeles, Los Angeles
Ap rekriteFaz 2
Laj 1 a 26 · Tout sèks · Mizajou Aug 4, 2026 · NCT07680439Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- Eden Medical Center, Castro Valley
- UCSD Moores Cancer Center, La Jolla
- MemorialCare Health System, Laguna Hills
- ak 2 plis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 22, 2026 · NCT04427384Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT06580002An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis
- City of Hope Medical Center, Duarte
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Jul 1, 2026 · NCT05376878Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- Stanford University School of Medicine, Palo Alto
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT03510208REMASTer: REcurrent Brain Metastases After SRS Trial
- UCLA, Los Angeles
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 18, 2026 · NCT05124912Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
- Moores Cancer Center, San Diego
Ap rekriteEtid obsèvasyon
Laj 18 a 99 · Tout sèks · Mizajou Jun 10, 2026 · NCT05576103Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
- City of Hope Corona, Corona
- City of Hope Comprehensive Cancer Center, Duarte
- City of Hope at Irvine Lennar, Irvine
- ak 4 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jun 9, 2026 · NCT03550391Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma
- University of California San Francisco, San Francisco
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou May 19, 2026 · NCT07418775Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases
- Stanford University, Palo Alto
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 18, 2026 · NCT06712927Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- University of California, Irvine, Irvine
- University of California Los Angeles, Los Angeles
- University of California at San Francisco, San Francisco
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT06810544Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements
- Stanford University, Stanford
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Apr 8, 2026 · NCT05987644CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children
- City of Hope Medical Center, Duarte
- Children's Hospital Los Angeles, Los Angeles
Ap rekriteFaz 1
Laj 4 a 25 · Tout sèks · Mizajou Mar 5, 2026 · NCT04510051Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer
- The University of California Davis Comprehensive Cancer Center, Sacramento
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Feb 27, 2026 · NCT05452005Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Feb 5, 2026 · NCT06650163cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- City of Hope, Duarte
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jan 15, 2026 · NCT07339085S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- City of Hope Comprehensive Cancer Center, Duarte
- USC / Norris Comprehensive Cancer Center, Los Angeles
- Contra Costa Regional Medical Center, Martinez
- ak 5 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 8, 2025 · NCT03418961APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 27, 2025 · NCT03175224The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
- University of California, San Francisco, San Francisco
Ap rekriteEtid obsèvasyon
Jiska laj 90 · Tout sèks · Mizajou Feb 22, 2024 · NCT06273176The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
- University of California, San Francisco (UCSF), San Francisco
Ap rekriteEtid obsèvasyon
Laj 18 a 90 · Tout sèks · Mizajou Feb 22, 2024 · NCT06118723Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.